The net loss for Intellia Therapeutics in 2024 amounted to some 519 million U.S. dollars. The statistic illustrates the net loss for Intellia between 2014 and 2024. Intellia is a biotech company that produces therapeutics using CRISPR technology.
Net loss of Intellia Therapeutics from 2014 to 2024
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Intellia Therapeutics, & U.S. Securities and Exchange Commission. (February 27, 2025). Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 06, 2025, from https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, und U.S. Securities and Exchange Commission. "Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars)." Chart. February 27, 2025. Statista. Accessed June 06, 2025. https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, U.S. Securities and Exchange Commission. (2025). Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 06, 2025. https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, and U.S. Securities and Exchange Commission. "Net Loss of Intellia Therapeutics from 2014 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 27 Feb 2025, https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics & U.S. Securities and Exchange Commission, Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/ (last visited June 06, 2025)
Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph], Intellia Therapeutics, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
